Hologic

Health Care Health Care Equipment Marlborough, Massachusetts Last filing Nov 18, 2025 · FY2025

                    Revenue
                    FY2025
                
$4.1B
                    3y CAGR -5.5%
                    
                    P5
                    
                    +1.7%
                    
                    Net income
                    FY2025
                
$565.7M
                    Net margin +13.8%
                    
                    P58
                    
                    -28.3%
                    
                    Total assets
                    FY2025
                
$9.0B
                    ROA +6.3%
                    
                    P55
                    
                    -1.5%
                    
                    Operating cash flow
                    FY2025
                
$1.1B
                    FCF margin +24.3%
                    
                    P88
                    
                    -17.7%

20 yrs · FY2006–FY2025 1 quarantined 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

35 accounts · 5 years

Total assets $9.0B

Total liabilities $977.2M

Shareholders equity $5.0B

Account	2025	2024	2023	2022	2021
Assets
Cash and Cash Equivalents	47.8%	53.6%	67.5%	48.1%	20.8%
Short Term Investments	5.9%	—	—	—	—
Accounts Receivable	14.7%	14.9%	15.5%	12.7%	16.7%
Inventory	16.6%	—	—	12.8%	8.9%
Prepaid Expenses	3.7%	—	—	4.8%	9.4%
Other Current Assets	13.6%	—	—	4.3%	4.4%
Total Current Assets	89.5%	94.9%	103.8%	79.4%	56.3%
Property,Plant and Equipment	13.6%	13.3%	12.8%	9.9%	10.0%
Operating Lease Assets	0.1%	—	—	1.4%	1.5%
Goodwill	88.8%	85.4%	81.4%	66.6%	58.3%
Intangible Assets	14.4%	—	—	26.3%	29.5%
Long Term Investments	1.3%	—	—	—	—
Other Noncurrent Assets	13.6%	10.2%	6.6%	4.3%	4.4%
Total Assets	219.8%	227.2%	226.8%	186.5%	158.4%
Liabilities
Accounts Payable	4.7%	5.1%	4.3%	4.1%	3.8%
Accrued Liabilities	14.1%	14.4%	13.3%	11.0%	10.6%
Deferred Revenue	4.9%	—	—	3.8%	3.5%
Current Portion of Long Term Debt	0.1%	—	—	0.3%	5.6%
Operating Lease Liabilities	0.1%	—	—	0.5%	0.5%
Other Current Liabilities	10.2%	—	—	6.8%	6.5%
Total Current Liabilities	23.8%	25.7%	30.0%	19.3%	23.6%
Long Term Debt	61.1%	62.0%	62.8%	57.8%	48.2%
Deferred Revenue Noncurrent	0.3%	—	—	0.2%	0.4%
Operating Lease Liabilities Noncurrent	0.2%	—	—	1.1%	1.2%
Deferred Tax Liabilities	1.1%	—	—	1.9%	4.4%
Other Noncurrent Liabilities	10.2%	10.1%	8.3%	6.8%	6.5%
Total Liabilities	23.8%	—	—	19.3%	23.6%
Equity
Preferred Stock	0.0%	0.0%	0.0%	0.0%	0.0%
Common Stock	0.1%	0.1%	0.1%	0.1%	0.1%
Additional Paid In Capital	154.7%	154.9%	152.4%	124.3%	105.9%
Retained Earnings	83.2%	—	—	32.9%	5.3%
Treasury Stock	112.5%	95.6%	75.3%	52.1%	35.3%
Accumulated Other Comprehensive Income	-2.5%	—	—	-4.9%	-1.0%
Total Stockholders Equity	123.1%	127.3%	124.5%	100.3%	74.9%
Total Liabilitiesand Equity	219.8%	—	—	186.5%	158.4%

Income Statement

Revenue, expense, and profitability

21 accounts · 5 years

Revenue $4.1B

Operating income $714.3M

Net income $565.7M

Account	2025	2024	2023	2022	2021
IncomeStatement
Revenues Total Revenue	100.0%	—	—	100.0%	100.0%
Expenses Cost of Revenue	39.0%	—	—	—	—
Expenses Research and Development	6.1%	—	—	5.8%	4.9%
Expenses Selling,General and Administrative	11.0%	—	—	8.4%	7.7%
Expenses Depreciation and Amortization	0.4%	—	—	0.9%	0.7%
Expenses Share Based Compensation	2.1%	—	—	1.4%	1.2%
Expenses Restructuring and Asset Impairment	0.7%	—	—	0.0%	0.2%
Expenses Operating Expenses	34.2%	—	—	27.9%	23.4%
Other Income Expense Gross Profit	51.6%	55.3%	51.4%	61.6%	67.4%
Other Income Expense Operating Income	17.4%	—	—	33.7%	44.0%
Other Income Expense Interest Income	1.8%	2.7%	3.0%	0.3%	0.0%
Other Income Expense Interest Expense	2.9%	3.0%	2.8%	2.0%	1.7%
Other Income Expense Other Income/expense	0.2%	—	—	0.6%	-0.1%
Other Income Expense Income Before Tax	16.6%	—	—	32.7%	41.9%
Income Tax Income Tax Expense	2.8%	—	—	5.9%	8.7%
net Income net Income	13.8%	—	—	26.8%	33.2%
net Income Comprehensive Income	14.1%	—	—	23.1%	33.1%
Earnings Per Share Basic Eps	0.0%	—	—	0.0%	0.0%
Earnings Per Share Diluted Eps	0.0%	—	—	0.0%	0.0%
Earnings Per Share Weighted Average Shares Basic	5.5%	—	—	5.2%	4.6%
Earnings Per Share Weighted Average Shares Diluted	5.5%	—	—	5.2%	4.6%

Cash Flow Statement

Operating, investing, and financing flows

18 accounts · 5 years

Operating cash flow $1.1B

Investing cash flow $-482.7M

Financing cash flow $-777.2M

Account	2025	2024	2023	2022	2021
CashFlow
Operating Activities net Income	13.8%	19.6%	11.3%	26.8%	33.2%
Operating Activities Depreciation and Amortization	2.7%	2.5%	2.2%	1.8%	1.6%
Operating Activities Stock Based Compensation	2.1%	—	—	1.4%	1.2%
Operating Activities Deferred Income Taxes	-3.5%	-1.8%	-2.7%	-3.4%	-1.2%
Operating Activities Changes In Operating Assets and Liabilities	-1.9%	-0.0%	-0.4%	-11.6%	1.0%
Operating Activities net Cash From Operating Activities	25.8%	—	—	43.7%	41.4%
Investing Activities Capital Expenditures	1.4%	—	—	1.5%	2.1%
Investing Activities Business Acquisitions	7.8%	—	—	3.3%	20.7%
Investing Activities Purchases of Investments	3.6%	—	—	0.0%	—
Investing Activities Other Investing Activities	0.1%	0.0%	0.2%	-0.1%	0.0%
Investing Activities net Cash From Investing Activities	-11.8%	—	—	-4.2%	-23.6%
Financing Activities Repurchase of Common Stock	18.4%	—	—	11.1%	7.3%
Financing Activities Proceeds From Stock Issuance	0.9%	—	—	0.7%	0.9%
Financing Activities net Cash From Financing Activities	-19.0%	—	—	-15.5%	-9.4%
Cash Reconciliation Effect of Exchange Rate On Cash	0.1%	—	—	0.1%	-0.0%
Cash Reconciliation net Change In Cash	-4.9%	—	—	24.0%	8.3%
Cash Reconciliation Cash At Beginning of Period	47.8%	—	—	48.1%	20.8%
Cash Reconciliation Cash At End of Period	47.8%	—	—	48.1%	20.8%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 5 years

Ratio	2025	2024	2023	2022	2021
Profitability
Gross margin	+61.0%	—	—	—	—
Operating margin	+17.4%	+21.9%	+16.6%	+33.7%	+44.0%
Net margin	+13.8%	+19.6%	+11.3%	+26.8%	+33.2%
FCF margin	+24.3%	+30.1%	+23.8%	+42.3%	+39.3%
Growth
Revenue CAGR (3y)	-5.5%	-10.6%	+2.2%	—	+20.5%
Returns
ROE	+11.2%	+15.4%	+9.1%	+26.7%	+44.4%
ROA	+6.3%	+8.6%	+5.0%	+14.4%	+21.0%
ROIC	+10.6%	+16.0%	+13.1%	+25.1%	+32.3%
Liquidity
Current ratio	3.75x	3.69x	3.47x	4.12x	2.39x
Quick ratio	2.62x	2.66x	2.77x	3.15x	1.59x
Leverage
D/E	0.19x	0.78x	0.82x	0.19x	0.31x
Interest coverage	6.10x	7.23x	6.02x	17.25x	26.50x
Efficiency
Asset turnover	0.45x	0.44x	0.44x	0.54x	0.63x
Cash conversion cycle	+164d	—	—	—	—

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

Hologic

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history